Next-Gen D-TZD

N/A

Report date: 2025/03/20 15:17:25
NME

Base Information

Drug NameNext-Gen D-TZD
Drug Alias Namedeuterated thiazolidinedione (Poxel)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMitochondrial pyruvate carrier inhibitors
TargetsMitochondrial pyruvate carrier
Therapy Area/IndicationsMetabolic DiseasesKidney Failure, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryFrance
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPoxel Sa
China Registration ClassN/A

Develop Information

Active CompaniesPoxel Sa
Inactive CompaniesN/A
Active IndicationsMetabolic DiseasesKidney Failure, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A